These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 30261314)

  • 21. Cardiac Fgf-16 Expression Supports Cardiomyocyte Survival and Increases Resistance to Doxorubicin Cytotoxicity.
    Wang J; Xiang B; Dolinsky VW; Kardami E; Cattini PA
    DNA Cell Biol; 2018 Nov; 37(11):866-877. PubMed ID: 30230915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The regulatory mechanisms of myogenin expression in doxorubicin-treated rat cardiomyocytes.
    Liu ST; Huang SM; Ho CL; Yen LC; Huang CJ; Lin WS; Chan JY
    Oncotarget; 2015 Nov; 6(35):37443-57. PubMed ID: 26452256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiRNA-30e mediated cardioprotection of ACE2 in rats with Doxorubicin-induced heart failure through inhibiting cardiomyocytes autophagy.
    Lai L; Chen J; Wang N; Zhu G; Duan X; Ling F
    Life Sci; 2017 Jan; 169():69-75. PubMed ID: 27633839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemical Endoplasmic Reticulum Chaperone Alleviates Doxorubicin-Induced Cardiac Dysfunction.
    Fu HY; Sanada S; Matsuzaki T; Liao Y; Okuda K; Yamato M; Tsuchida S; Araki R; Asano Y; Asanuma H; Asakura M; French BA; Sakata Y; Kitakaze M; Minamino T
    Circ Res; 2016 Mar; 118(5):798-809. PubMed ID: 26838784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microarray and Co-expression Network Analysis of Genes Associated with Acute Doxorubicin Cardiomyopathy in Mice.
    Wei SN; Zhao WJ; Zeng XJ; Kang YM; Du J; Li HH
    Cardiovasc Toxicol; 2015 Oct; 15(4):377-93. PubMed ID: 25575753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basal autophagy protects cardiomyocytes from doxorubicin-induced toxicity.
    Pizarro M; Troncoso R; Martínez GJ; Chiong M; Castro PF; Lavandero S
    Toxicology; 2016 Aug; 370():41-48. PubMed ID: 27666003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythropoietin activates SIRT1 to protect human cardiomyocytes against doxorubicin-induced mitochondrial dysfunction and toxicity.
    Cui L; Guo J; Zhang Q; Yin J; Li J; Zhou W; Zhang T; Yuan H; Zhao J; Zhang L; Carmichael PL; Peng S
    Toxicol Lett; 2017 Jun; 275():28-38. PubMed ID: 28456571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doxorubicin induces cardiomyocyte dysfunction via a p38 MAP kinase-dependent oxidative stress mechanism.
    Wold LE; Aberle NS; Ren J
    Cancer Detect Prev; 2005; 29(3):294-9. PubMed ID: 15936597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Change in TNF-alpha receptor expression is a relevant event in doxorubicin-induced H9c2 cardiomyocyte cell death.
    Chiosi E; Spina A; Sorrentino A; Romano M; Sorvillo L; Senatore G; D'Auria R; Abbruzzese A; Caraglia M; Naviglio S; Illiano G
    J Interferon Cytokine Res; 2007 Jul; 27(7):589-97. PubMed ID: 17651020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Embryonic stem cell-derived cardiomyocytes as a model system to study cardioprotective effects of dexamethasone in doxorubicin cardiotoxicity.
    Farokhpour M; Karbalaie K; Tanhaei S; Nematollahi M; Etebari M; Sadeghi HM; Nasr-Esfahani MH; Baharvand H
    Toxicol In Vitro; 2009 Oct; 23(7):1422-8. PubMed ID: 19596060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.
    van Almen GC; Swinnen M; Carai P; Verhesen W; Cleutjens JP; D'hooge J; Verheyen FK; Pinto YM; Schroen B; Carmeliet P; Heymans S
    J Mol Cell Cardiol; 2011 Sep; 51(3):318-28. PubMed ID: 21624372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naringenin-7-O-glucoside protects against doxorubicin-induced toxicity in H9c2 cardiomyocytes by induction of endogenous antioxidant enzymes.
    Han X; Pan J; Ren D; Cheng Y; Fan P; Lou H
    Food Chem Toxicol; 2008 Sep; 46(9):3140-6. PubMed ID: 18652870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro.
    Spallarossa P; Garibaldi S; Altieri P; Fabbi P; Manca V; Nasti S; Rossettin P; Ghigliotti G; Ballestrero A; Patrone F; Barsotti A; Brunelli C
    J Mol Cell Cardiol; 2004 Oct; 37(4):837-46. PubMed ID: 15380674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Propofol ameliorates doxorubicin-induced oxidative stress and cellular apoptosis in rat cardiomyocytes.
    Lai HC; Yeh YC; Wang LC; Ting CT; Lee WL; Lee HW; Wang KY; Wu A; Su CS; Liu TJ
    Toxicol Appl Pharmacol; 2011 Dec; 257(3):437-48. PubMed ID: 22015447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testosterone Antagonizes Doxorubicin-Induced Senescence of Cardiomyocytes.
    Altieri P; Barisione C; Lazzarini E; Garuti A; Bezante GP; Canepa M; Spallarossa P; Tocchetti CG; Bollini S; Brunelli C; Ameri P
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26746999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. L-carnitine reduces doxorubicin-induced apoptosis through a prostacyclin-mediated pathway in neonatal rat cardiomyocytes.
    Chao HH; Liu JC; Hong HJ; Lin JW; Chen CH; Cheng TH
    Int J Cardiol; 2011 Jan; 146(2):145-52. PubMed ID: 19552975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amidization of doxorubicin alleviates doxorubicin-induced contractile dysfunction and reduced survival in murine cardiomyocytes.
    Turdi S; Xu P; Li Q; Shen Y; Kerram P; Ren J
    Toxicol Lett; 2008 May; 178(3):197-201. PubMed ID: 18467042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis.
    Frias MA; Lang U; Gerber-Wicht C; James RW
    Cardiovasc Res; 2010 Jan; 85(1):118-26. PubMed ID: 19700468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ultrastructural manifestations of disturbances of cardiomyocyte regeneration after the doxorubicin treatment].
    Lushnikova EL; Nepomniashchich LM; Klinnikova MG; Molodykh OP
    Morfologiia; 2005; 128(4):81-4. PubMed ID: 16400929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HER2-targeted liposomal doxorubicin displays enhanced anti-tumorigenic effects without associated cardiotoxicity.
    Reynolds JG; Geretti E; Hendriks BS; Lee H; Leonard SC; Klinz SG; Noble CO; Lücker PB; Zandstra PW; Drummond DC; Olivier KJ; Nielsen UB; Niyikiza C; Agresta SV; Wickham TJ
    Toxicol Appl Pharmacol; 2012 Jul; 262(1):1-10. PubMed ID: 22676972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.